Pre-Market and the QSR Presented by: Dawn Fernandes.

Slides:



Advertisements
Similar presentations
Building a Cradle-to-Grave Approach with Your Design Documentation and Data Denise D. Dion, EduQuest, Inc. and Gina To, Breathe Technologies, Inc.
Advertisements

REGULATIONS for SUPPLIES, EQUIPMENT, REAGENTS and TESTING JILL HOAG BS, SBB(ASCP) CQA(ASQ) AABB STAFF LEAD ASSESSOR 1.
Radiopharmaceutical Production
SC 18 Ad Hoc Task Group API Staff Issues Ed Durante, Chair.
Transition from Q1- 8th to Q1- 9th edition
Understanding the Requirements Qimpro Standards Organization
GMP Document and Record Retention
ISO 9001 : 2000.
EPSON STAMPING ISO REV 1 2/10/2000.
SAE AS9100 Quality Systems - Aerospace Model for Quality Assurance
How is the Supply Chain Impacted by the FDA Purchasing Controls Regulatory Requirements? Teresa Jimenez Regulatory Expert Consultants, Inc. Oct. 4, 2012.
Biomedical Auditing. The Biomedical Auditor works with medical devices, including in vitro diagnostics and biologics that are regulated as medical devices.
Quality Management System
Learning from GMP Inspections. Richard Bateman QA Specialist Pharmacist East and South East England Specialist Pharmacy Services.
ISO 9001 Interpretation : Exclusions
Effective CAPA Program, a Valuable Tool in Quality Improvement Dharmi Trivedi.
FIELD COMPLIANCE UPDATE CDR Thomas R. Berry, RPh FDA, Investigator RAL-RP / ATL-DO.
External Defibrillators: Recalls, Inspections, and the Quality System Regulation Melissa Torres Office of Compliance December 15, 2010.
ISO 9001:2000 Intro Presented By: Brad D. Agenda Overview of QMS Fundamentals ISO 9001:2000 Overview & Requirements.
QC/QA Mary Malarkey Director, Division of Case Management Office of Compliance and Biologics Quality Center for Biologics Evaluation and Research March.
4. Quality Management System (QMS)
Top Tactics for Maximizing GMP Compliance in Blue Mountain RAM Jake Jacanin, Regional Sales Manager September 18, 2013.
4. Quality Management System (QMS)
Huzairy Hassan School of Bioprocess Engineering UniMAP.
World Health Organization
QUALITY MANAGEMENT SYSTEM ACCORDING TO ISO
Quality Management System
Quality Management Systems P.Suriya Prakash Final Mech Vcet
Regulatory Overview.
Introduction to ISO New and modified requirements.
Copyright 2005 Welcome to The Great Lakes TL 9000 SIG TL 9000 Requirements Release 3.0 to Release 4.0 Differences Bob Clancy Vice President, BIZPHYX,
The Role of the Internal Auditor for Maintaining System Compliance and Promoting Continuous Improvement Wayne M. Uttke
FDA Regulatory review in Minutes: What Product Development Executives Need-to-Know. Specifically, frequent causes of recalls and related areas that investigators.
Inspection Issues in the Analytical Laboratory: An FDA Perspective Yvonne McKnight Chemist US Food and Drug AdministrationPhone: x
Top 10 Medical Device Citations
ISO 9001:2000 QUALITY MANAGEMENT SYSTEM REQUIREMENTS
World Health Organization
Good Manufacturing Practice. Good Manufacturing Practice Regulations Establishes minimum GMP for methods to be used, and the facilities or controls to.
Visit us at E mail: Tele:
Development and Regulation of Medical Products (MEDR-101)
Product Development Chapter 6. Definitions needed: Verification: The process of evaluating compliance to regulations, standards, or specifications.
Kimberly A. Trautman FDA’s Medical Device Quality System Expert
This class cannot be shared or copied without the written permission of PracticeWorks Systems, LLC.
Proposed Rule for Preventive Controls for Animal Food.
Proposed Rule: 21 CFR 507 Proposed Rule for Preventive Controls for Animal Food 1.
QUALITY MANAGEMENT STATEMENT
Design Documentation Clint Kehres, Brian Krouse, Jenn Shafner.
Joel Gerber Zachary Reaver Kurt Schilling.  Provides physical proof of development  Maintains product design knowledge base  Meets government and corporate.
Final Rule on Foreign Supplier Verification Programs 1.
It was found in 1946 in Geneva, Switzerland. its main purpose is to promote the development of international standards to facilitate the exchange of goods.
The Second Annual Medical Device Regulatory, Reimbursement and Compliance Congress Presented by J. Glenn George Thursday, March 29, 2007 Day II – Track.
Chapter 19 Manufacturing and Quality Control
Good Manufacturing Practice (GMP) Compliance: GMPs EXPLAINED.
Joe Selva Rohan Thakkar Jean Valderrama.  “Documentation” is what’s written on paper  Provides written details, events, and information about a particular.
INTRODUCTION Quality System in Medical Devices ©2014 Salt Lake Community College. All rights reserved.
WORKSHOP ON ACCREDITATION OF BODIES CERTIFYING MEDICAL DEVICES INT MARKET TOPIC 9 CH 8 ISO MEASUREMENT, ANALYSIS AND IMPROVEMENT INTERNAL AUDITS.
Workshop on Accreditation of Bodies Certifying Medical Devices Kiev, November 2014.
CM&C Inspections The Pre-Approval Inspection (PAI) in the US 27 May 2010.
NANCY CHOBIN, RN, AAS, ACSP, CSPM, CFER CHOBIN & ASSOCIATES CONSULTING HOT TOPICS IN STERILIZATION AND DISINFECTION.
Complaint Handling Medical Device Reporting May 19, 2016 Rita Harden, Director Customer Relations & Regulatory Reporting.
1. Our Presentation Topic: Importance Of Validation & Qualification In Pharmaceutical Industries Presented By: Md. Tanjir Islam (Group C) 2.
Device regulations USA Dr Phil Warner. USA Regulations MEDICAL DEVICES Food, Drug & Cosmetics Act Medical Device Amendments of 1976 (and other things)
Raechel Huebner Ruthanne Sherer
Quality Assurance and Quality Control in Generics
Presented by: Michelle Johnston Quality System Consultant
FDA 21 CFR Part 11 Overview June 10, 2006.
FDA Quality System Regulation
Medical Device Design and Development
Radiopharmaceutical Production
Presentation transcript:

Pre-Market and the QSR Presented by: Dawn Fernandes

To Understand:  Why You Need a Quality System  When to Implement a Quality System  Effects of an Inadequate Quality System

With the exception of those Class I devices that are exempt from both premarket notification and GMPs, most devices are required to:  Be developed and manufactured according to 21 CFR 820, the Quality System Regulation  Have obtained appropriate premarket approval or clearance prior to distribution in commerce The exemption from premarket notification for certain Class I devices, does not always mean a device is exempt from the QSR requirements.

21 CFR § Scope. (a) Applicability. (1) Current good manufacturing practice (CGMP) requirements are set forth in this quality system regulation. The requirements in this part govern the methods used in, and the facilities and controls used for, the design, manufacture, packaging, labeling, storage, installation, and servicing of all finished devices intended for human use. The scope is manufacturing, and everything around it – i.e. product realization

In addition to the fact that compliance with the QSR is required, following the principles of Design Control as laid out in 21 CFR for design and development of a device provides an ordered context that facilitates: Planning Cross-functional communication Clarification of deliverables Identification of design deficiencies Verification that the design satisfies its identified requirements Successful transfer into production.

Successful Product Launch ! Higher Costs due to re-work Late Launch Requirements changing Design InPut Review Design Output Review V&V review Design Transfer Review A Poor or Non-Existent QS leads to : The FDA Phase-Gate Approach Encourages Good Project Practices Resource Headcount Months

Start of Project Launch to Market

Why do we need a Quality Management System if we aren’t even sure what our final device design will look like yet? As long as we have the Quality System in place before we’re doing commercial manufacture, we should be fine, right? Hey, we’re just doing the specification development - we’re not even manufacturing! Can’t we wait to see if our device is even approved by the FDA before we go through all of that trouble?

Hey, we’re just doing the specification development - we’re not even manufacturing! Per 21 CFR Definitions.  (o) Manufacturer means any person who designs, manufactures, fabricates, assembles, or processes a finished device. Manufacturer includes but is not limited to those who perform the functions of contract sterilization, installation, relabeling, remanufacturing, repacking, or specification development, and initial distributors of foreign entities performing these functions.

Can’t we wait to see if our device is even approved by the FDA before we go through all of that trouble? Recall Sec Scope.  (a) Applicability. (1) Current good manufacturing practice (CGMP) requirements are set forth in this quality system regulation. The requirements in this part govern the methods used in, and the facilities and controls used for, the design, manufacture, packaging, labeling, storage, installation, and servicing of all finished devices intended for human use. Other points to consider: Some 510(k) submission types require a declaration of conformity to ; and, a PMA will usually trigger an inspection.

Can’t we wait to see if our device is even approved by the FDA before we go through all of that trouble? SSec (b) Design and development planning. Each manufacturer shall establish and maintain plans that describe or reference the design and development activities and define responsibility for implementation. The plans shall identify and describe the interfaces with different groups or activities that provide, or result in, input to the design and development process. The plans shall be reviewed, updated, and approved as design and development evolves.

Why do we need a Quality Management System if we aren’t even sure what our final device design will look like yet?  Sec (c) Design input. Each manufacturer shall establish and maintain procedures to ensure that the design requirements relating to a device are appropriate and address the intended use of the device, including the needs of the user and patient. ….The approval, including the date and signature of the individual(s) approving the requirements, shall be documented.

The answer is that once the idea for a device leaves the proverbial napkin, a QMS must be in place and followed!

Start with the basics:  Quality Manual  Management Responsibility  Document & Records Control procedures  Training procedure  Design Control procedures  Risk Management procedures  CAPA, Nonconformances  Change Control

Then, add procedures for other elements before they’re actually needed; for example:  Equipment Qualification, Operation, Calibration & Maintenance procedures  Housekeeping and Environmental Control procedures  Test Methods  Purchasing Controls and Vendor Qualification procedures  Validation procedures (VMP? But, that’s another )

Some procedures may be implemented later than others as the Quality System develops. The key is to ensure all required procedures are in place prior to conducting activities governed by the procedure. Once a Quality System has been established, it is important to verify its effectiveness through monitoring of key metrics, internal audits and Management Review.

 Withholding of regulatory approvals/clearances – rejected submissions  483s or Warning Letters  Injunction or Consent Decree  Customer Complaints  Adverse Events  Recalls  Seizure

2014 – over 590 warning letters issued!!! 2015 – over 375 warning letters issued through May!!!

 Depending on the year referenced, the percentage of Warning Letters containing citations related to inadequate Design Controls is around 47 to 61%.  This is one of the most commonly cited subsystems, with Production and Process controls, CAPA, and Complaint file deficiencies rounding out the top categories.

 Review the provided Warning Letter  Determine which of the citations you feel may be evidence of a QMS that was not fully implemented prior to development activities  Discuss the implications

Distribute hard copy to group

What did you find? 3. Failure to establish and maintain adequate procedures for verifying the device design. Design verification shall confirm that the design output meets the design input requirements, as required by 21 CFR (f). For example: a.Your firm failed to validate the (b)(4) test methods implemented during the Durata design verification testing. These test methods were created in-house to verify your firm’s design inputs; however, they were not based on and did not follow a national standard. b.Your firm failed to follow its test procedure, (b)(4) Rev. D, released 05/09/2003, during design verification testing of the (b)(4). Specifically, the procedure required each lead to be tested 5 times and the mean of the 5 tests would be considered the result. However, your firm only tested each lead one time to determine the results. c.Your firm performed design verification of the Durata lead prior to establishing design inputs. Specifically, your firm performed the design verification study to ensure the (b)(4) was not excessive on June 7, 2007, prior to establishing the design input that “the (b)(4) of the (b)(4) shall be (b)(4)” on July 16, 2007.

What did you find? 4. Failure to establish and maintain a design history file for each type of device, as required by 21 CFR (j). For example, your firm was unable to demonstrate when key elements of a design history file for the Durata design project were conducted and approved, such as design inputs, outputs, verification, validation, and design transfer.

Actually, any of the citations in the Warning Letter could be taken as evidence of a QMS that has not been fully implemented, as many of the deficiencies are prefaced with ‘failure to establish and maintain procedures’ for the cited element. The take away message from this solitary example, out of so many like it, is that an effective QMS must be implemented early, must encompass the activities you’re performing, and must be reviewed to ensure effectiveness.

Thank you for your participation!!!!